Market Trends Praxis stock downgraded at Wedbush on trial setback (update) (PRAX:NASDAQ)By admin8996erT0allFebruary 28, 2025 Praxis Precision Medicines (NASDAQ:PRAX) announced Friday that the company will advance its Essential3 program for its lead asset ulixacaltamide against…
